title: Role of radiotherapy in early glottic carcinoma.
abstract: BACKGROUND
  Early glottic carcinoma has a high local control prospect with radiotherapy. This review evaluates a single center's experience.
  
  
  METHODS
  All patients from 1967 to 2006 diagnosed with Tis/T1/T2/N0 early glottic carcinoma treated definitively with radiotherapy at Prince of Wales Hospital were reviewed. Local control and cancer-specific survival (CSS) rates were primary endpoints, and the impact of various factors on these outcomes was statistically analyzed.
  
  
  RESULTS
  This review of 522 patients includes 24 with Tis, 356 with T1, and 142 with T2. Ultimate local control rates were as follows: Tis 87.5%, T1 94.7%, and T2 84.5%. Multivariate analysis found fitness for surgery, no involvement of anterior commissure, normal cord movement, and radiotherapy dose >60 Gy significant for local control. Fitness for surgery, no involvement of the anterior commissure, normal cord movement, and no ventricular involvement were significant prognostic factors for CSS.
  
  
  CONCLUSIONS
  Definitive radiotherapy for early glottic carcinoma provides high local control rates, with the option of surgical salvage to achieve ultimate local control.
authors.affiliation: Department of Radiation Oncology, The Prince of Wales Cancer Centre, High Street, Randwick, New South Wales 2031, Australia. robert.smee@sesiahs.health.nsw.gov.au
authors.forename: Robert I
authors.initials: RI
authors.lastname: Smee
authors.forename: Nicola S
authors.initials: NS
authors.lastname: Meagher
authors.forename: Janet R
authors.initials: JR
authors.lastname: Williams
authors.forename: Kathryn
authors.initials: K
authors.lastname: Broadley
authors.forename: G Patrick
authors.initials: GP
authors.lastname: Bridger
mesh_terms: D000368:Aged; D002277:Carcinoma / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D015331:Cohort Studies; D005260:Female; D005931:Glottis; D006801:Humans; D007822:Laryngeal Neoplasms / Q000401:mortality / Q000473:pathology / Q000532:radiotherapy*; D008297:Male; D008875:Middle Aged; D009367:Neoplasm Staging; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome